Association Between KRAS Variant Status and Outcomes with First-line Immune Checkpoint Inhibitor-Based Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.
JAMA Oncology（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined